<i>Candida auris</i>-associated hospitalizations and outbreaks, China, 2018-2023.

"in total 53 genomic sequences of clinical strains (23 previously sequenced and 30 sequenced in this study dataset s1) representing 51 independent cases from china in addition to 2 environmental strains were analyzed."

"Disclosure statement Clarissa J. Nobile is a cofounder of BioSynesis, Inc., a company developing diagnostics and therapeutics for biofilm infections."

"This work was supported by the National Key Research and Development Program of China (grant number 2021YFC2300400 to G.H. and no. 2022YFC2303000 to H.D. and J.B.), National Natural Science Foundation of China (award 31930005 and 82272359 to G.H., nos. 32170193 and 32000018 to J.B., and 82172290 and 82002123 to H.D), and the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) (grant R35GM124594 to CJN) and by the Kamangar family in the form of an endowed chair (to CJN). The content is the sole responsibility of the authors and does not represent the views of the funders. The funders had no role in the design of the study; in the collection, analyzes, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results."